Glial Fibrillary Acidic Protein Autoimmunity A French Cohort Study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Neurology Année : 2022

Glial Fibrillary Acidic Protein Autoimmunity A French Cohort Study

(1) , (2) , (3, 4, 5, 6) , (1) , (4, 7) , (3, 4) , (3, 4) , (3, 4, 5, 6) , (3, 4, 5, 6) , (8) , , (9, 8) , (10) , , (11) , (12) , (13) , , , (14) , (15) , (16) , (17) , , (18) , (19) , (20) , (18) , (18) , (21) , (22) , (23) , (24) , (25, 26) , , (27) , , (28) , , , , (29) , , (30) , , (4, 7) , (3)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Florence Rulquin
  • Fonction : Auteur
Thomas De Broucker
  • Fonction : Auteur
Laurent Kremer
  • Fonction : Auteur
Bastien Bouldoires
  • Fonction : Auteur
Roxana Genet
  • Fonction : Auteur
Elena-Camelia Rusu
  • Fonction : Auteur
Eve Chanson
  • Fonction : Auteur
Philippe Diraison
  • Fonction : Auteur
Celine Derollez
  • Fonction : Auteur
Quentin Bodard
Clementine Fort
  • Fonction : Auteur
Irina Grigorashvili-Coin
  • Fonction : Auteur
Daniela Molinier-Tiganas
  • Fonction : Auteur
Mickael Bonnan
  • Fonction : Auteur
Thierry Tchoumi
  • Fonction : Auteur

Résumé

Background and Objectives To report the clinical, biological, and imaging features and clinical course of a French cohort of patients with glial fibrillary acidic protein (GFAP) autoantibodies. Methods We retrospectively included all patients who tested positive for GFAP antibodies in the CSF by immunohistochemistry and confirmed by cell-based assay using cells expressing human GFAP alpha since 2017 from 2 French referral centers. Results We identified 46 patients with GFAP antibodies. Median age at onset was 43 years, and 65% were men. Infectious prodromal symptoms were found in 82%. Other autoimmune diseases were found in 22% of patients, and coexisting neural autoantibodies in 11%. Tumors were present in 24%, and T-cell dysfunction in 23%. The most frequent presentation was subacute meningoencephalitis (85%), with cerebellar dysfunction in 57% of cases. Other clinical presentations included myelitis (30%) and visual (35%) and peripheral nervous system involvement (24%). MRI showed perivascular radial enhancement in 32%, periventricular T2 hyperintensity in 41%, brainstem involvement in 31%, leptomeningeal enhancement in 26%, and reversible splenial lesions in 4 cases. A total of 33 of 40 patients had a monophasic course, associated with a good outcome at last follow-up (Rankin Score <= 2: 89%), despite a severe clinical presentation. Adult and pediatric features are similar. Thirty-two patients were treated with immunotherapy. A total of 11/22 patients showed negative conversion of GFAP antibodies. Discussion GFAP autoimmunity is mainly associated with acute/subacute meningoencephalomyelitis with prodromal symptoms, for which tumors and T-cell dysfunction are frequent triggers. The majority of patients followed a monophasic course with a good outcome.
Fichier principal
Vignette du fichier
Glial_Fibrillary_Acidic_Protein_Autoimmunity_A_Fre.pdf (1.1 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03578197 , version 1 (15-06-2022)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification - CC BY 4.0

Identifiants

Citer

Alice Gravier-Dumonceau, Roxana Ameli, Veronique Rogemond, Anne Ruiz, Bastien Joubert, et al.. Glial Fibrillary Acidic Protein Autoimmunity A French Cohort Study. Neurology, 2022, 98 (6), pp.E653-E668. ⟨10.1212/WNL.0000000000013087⟩. ⟨hal-03578197⟩
98 Consultations
33 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More